**Core Concept**
Atropine toxicity is a life-threatening condition caused by the accumulation of acetylcholine and the subsequent blockade of muscarinic receptors in the central and peripheral nervous systems. The primary goal of treatment is to counteract the anticholinergic effects of atropine by increasing the concentration of acetylcholine in the synaptic cleft.

**Why the Correct Answer is Right**
Physostigmine is a reversible cholinesterase inhibitor that increases the concentration of acetylcholine in the synaptic cleft by preventing its breakdown. It crosses the blood-brain barrier, allowing it to effectively counteract the central anticholinergic effects of atropine, such as delirium and coma. Physostigmine also has a relatively narrow therapeutic index, making it a specific treatment for atropine toxicity.

**Why Each Wrong Option is Incorrect**
**Option A:** Pralidoxime is a reactivator of acetylcholinesterase, which is useful in organophosphate poisoning but not effective in atropine toxicity.
**Option B:** Naloxone is an opioid antagonist used to reverse opioid overdose, and it is not indicated in atropine toxicity.
**Option C:** Flumazenil is a benzodiazepine antagonist used to reverse benzodiazepine overdose, and it is not effective in atropine toxicity.

**Clinical Pearl / High-Yield Fact**
Physostigmine should be used with caution in patients with seizure disorders or cardiac conduction abnormalities, as it can exacerbate these conditions.

**Correct Answer:**
✓ Correct Answer: D. Physostigmine